1 - 25 of 84 results for uniprot:O15530 in Computationally mapped citations
Results Customize
| Involvement of Hsp90 in signaling and stability of 3-phosphoinositide-dependent kinase-1. Fujita N., Sato S., Ishida A., Tsuruo T. J. Biol. Chem. 277:10346-10353(2002) GeneRIF 5170 · Mapped (13) |
| Substitution of the autophosphorylation site Thr516 with a negatively charged residue confers constitutive activity to mouse 3-phosphoinositide-dependent protein kinase-1 in cells. Wick M.J., Wick K.R., Chen H., He H., Dong L.Q., Quon M.J., Liu F. J. Biol. Chem. 277:16632-16638(2002) GeneRIF 5170 · Mapped (12) |
| Membrane localization of 3-phosphoinositide-dependent protein kinase-1 stimulates activities of Akt and atypical protein kinase C but does not stimulate glucose transport and glycogen synthesis in 3T3-L1 adipocytes. Egawa K., Maegawa H., Shi K., Nakamura T., Obata T., Yoshizaki T., Morino K., Shimizu S., Nishio Y., Suzuki E. et al. J. Biol. Chem. 277:38863-38869(2002) GeneRIF 5170 · Mapped (5) |
| A phosphoserine/threonine-binding pocket in AGC kinases and PDK1 mediates activation by hydrophobic motif phosphorylation. Frodin M., Antal T.L., Dummler B.A., Jensen C.J., Deak M., Gammeltoft S., Biondi R.M. EMBO J. 21:5396-5407(2002) GeneRIF 5170 · Mapped (5) |
| PDK1-dependent activation of atypical PKC leads to degradation of the p21 tumour modifier protein. Scott M.T., Ingram A., Ball K.L. EMBO J. 21:6771-6780(2002) GeneRIF 5170 · Mapped (5) |
| In vivo role of the PIF-binding docking site of PDK1 defined by knock-in mutation. Collins B.J., Deak M., Arthur J.S., Armit L.J., Alessi D.R. EMBO J. 22:4202-4211(2003) GeneRIF 5170 · Mapped (17) |
| Phosphoinositide-dependent kinase 1 and p21-activated protein kinase mediate reactive oxygen species-dependent regulation of platelet-derived growth factor-induced smooth muscle cell migration. Weber D.S., Taniyama Y., Rocic P., Seshiah P.N., Dechert M.A., Gerthoffer W.T., Griendling K.K. Circ. Res. 94:1219-1226(2004) GeneRIF 5170 · Mapped (10) |
| Role of T-loop phosphorylation in PDK1 activation, stability, and substrate binding. Komander D., Kular G., Deak M., Alessi D.R., van Aalten D.M. J. Biol. Chem. 280:18797-18802(2005) GeneRIF 5170 PDB 2BIY · Mapped (5) |
| PDK1 nucleates T cell receptor-induced signaling complex for NF-kappaB activation. Lee K.Y., D'Acquisto F., Hayden M.S., Shim J.H., Ghosh S. Science 308:114-118(2005) GeneRIF 5170 · Mapped (6) |
| Elevated phosphorylation and activation of PDK-1/AKT pathway in human breast cancer. Lin H.J., Hsieh F.C., Song H., Lin J. Br. J. Cancer 93:1372-1381(2005) GeneRIF 5170 · Mapped (5) |
| 3-phosphoinositide-dependent protein kinase-1 (PDK1) promotes invasion and activation of matrix metalloproteinases. Xie Z., Yuan H., Yin Y., Zeng X., Bai R., Glazer R.I. BMC Cancer 6:77-77(2006) GeneRIF 5170 · Mapped (28) |
| Steady-state kinetic mechanism of PDK1. Gao X., Harris T.K. J. Biol. Chem. 281:21670-21681(2006) GeneRIF 5170 · Mapped (5) |
| Investigation of interleukin 1beta-mediated regulation of NF-kappaB activation in colonic cells reveals divergence between PKB and PDK-transduced events. Parhar K., Eivemark S., Assi K., Gomez-Munoz A., Yee A., Salh B. Mol. Cell. Biochem. 300:113-127(2007) GeneRIF 5170 · Mapped (16) |
| The role of PKC and PDK1 in monocyte lineage specification by Ras. Pearn L., Fisher J., Burnett A.K., Darley R.L. Blood 109:4461-4469(2007) GeneRIF 5170 · Mapped (17) |
| Loss of PTEN expression does not contribute to PDK-1 activity and PKC activation-loop phosphorylation in Jurkat leukaemic T cells. Freeley M., Park J., Yang K.J., Wange R.L., Volkov Y., Kelleher D., Long A. Cell. Signal. 19:2444-2457(2007) GeneRIF 5170 · Mapped (8) |
| 3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis. Hayashi T., Mo J.H., Gong X., Rossetto C., Jang A., Beck L., Elliott G.I., Kufareva I., Abagyan R., Broide D.H. et al. Proc. Natl. Acad. Sci. U.S.A. 104:18619-18624(2007) GeneRIF 5170 · Mapped (5) |
| PDK1 regulates cancer cell motility by antagonising inhibition of ROCK1 by RhoE. Pinner S., Sahai E. Nat. Cell Biol. 10:127-137(2008) GeneRIF 5170 · Mapped (15) |
| Phospholipidosis and down-regulation of the PI3-K/PDK-1/Akt signalling pathway are vitamin E inhibitable events associated with 7-ketocholesterol-induced apoptosis. Vejux A., Guyot S., Montange T., Riedinger J.M., Kahn E., Lizard G. J. Nutr. Biochem. 20:45-61(2009) GeneRIF 5170 · Mapped (13) |
| Multiple genetic variants along candidate pathways influence plasma high-density lipoprotein cholesterol concentrations. Lu Y., Dolle M.E., Imholz S., van 't Slot R., Verschuren W.M., Wijmenga C., Feskens E.J., Boer J.M. J. Lipid Res. 49:2582-2589(2008) GeneRIF 5170 GAD 594365 · Mapped (1,218) |
| PKCdelta survival signaling in cells containing an activated p21Ras protein requires PDK1. Xia S., Chen Z., Forman L.W., Faller D.V. Cell. Signal. 21:502-508(2009) GeneRIF 5170 · Mapped (49) |
| c-Jun regulates phosphoinositide-dependent kinase 1 transcription: implication for Akt and protein kinase C activities and melanoma tumorigenesis. Lopez-Bergami P., Kim H., Dewing A., Goydos J., Aaronson S., Ronai Z. J. Biol. Chem. 285:903-913(2010) GeneRIF 5170 · Mapped (8) |
| Reciprocal negative regulation of PDK1 and ASK1 signaling by direct interaction and phosphorylation. Seong H.A., Jung H., Ichijo H., Ha H. J. Biol. Chem. 285:2397-2414(2010) GeneRIF 5170 · Mapped (27) |
| Selective disruption of insulin-like growth factor-1 (IGF-1) signaling via phosphoinositide-dependent kinase-1 prevents the protective effect of IGF-1 on human cancer cell death. Alberobello A.T., D'Esposito V., Marasco D., Doti N., Ruvo M., Bianco R., Tortora G., Esposito I., Fiory F., Miele C. et al. J. Biol. Chem. 285:6563-6572(2010) GeneRIF 5170 · Mapped (12) |
| Genetic inactivation of AKT1, AKT2, and PDPK1 in human colorectal cancer cells clarifies their roles in tumor growth regulation. Ericson K., Gan C., Cheong I., Rago C., Samuels Y., Velculescu V.E., Kinzler K.W., Huso D.L., Vogelstein B., Papadopoulos N. Proc. Natl. Acad. Sci. U.S.A. 107:2598-2603(2010) GeneRIF 5170 · Mapped (18) |
| Mutational and immunohistochemical study of the PI3K/Akt pathway in papillary thyroid carcinoma in Greece. Sozopoulos E., Litsiou H., Voutsinas G., Mitsiades N., Anagnostakis N., Tseva T., Patsouris E., Tseleni-Balafouta S. Endocr. Pathol. 21:90-100(2010) GeneRIF 5170 · Mapped (30) |

